<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23905" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Kleihauer Betke Test</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Krywko</surname>
            <given-names>Diann M.</given-names>
          </name>
          <aff>Medical University of South Carolina</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yarrarapu</surname>
            <given-names>Siva Naga S.</given-names>
          </name>
          <aff>Monmouth Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shunkwiler</surname>
            <given-names>Sara M.</given-names>
          </name>
          <aff>UNMC</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Diann Krywko declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Siva Naga Yarrarapu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sara Shunkwiler declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23905.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Fetomaternal hemorrhage (FMH)&#x000a0;occurs when there is a break in the placental barrier, allowing blood from the fetal circulation to enter the maternal circulation. This disruption in the placental barrier may occur for many reasons, including intrauterine fetal demise and trauma. Trauma is the number&#x000a0;1 cause of pregnancy-associated maternal deaths in the United States.<xref ref-type="bibr" rid="article-23905.r1">[1]</xref>&#x000a0;It occurs in as many as 40% of traumas, increasing in frequency and amount with high-force trauma, blunt-force trauma, abdominal trauma, and anterior placental placement in the uterus.</p>
        <p>When FMH occurs, fetal hemoglobin (HbF) is mixed with maternal blood. In response to this exposure, the maternal immune system is activated, and isoimmunization (formation of anti-RhD antibodies) may occur if the mother is Rhesus-D protein (RhD) negative and the blood type of the fetus is RhD positive. It takes only 0.01 ml to 0.03 ml of FMH for the isoimmunization of the mother<bold>.&#x000a0;</bold>Future pregnancies may be at risk for RhD disease if the fetus is RhD-positive.&#x000a0;The maternal antibodies bind to fetal RhD-positive erythrocytes, leading to hemolysis, anemia, hydrops fetalis, and possibly fetal death.</p>
        <p>To prevent the formation of anti-RhD antibodies, Rho(D) immune globulin is indicated. Before 12 weeks gestational age, in the setting of an RhD-negative mother and FMH, a mini-dose of 150 mcg Rho(D) immune globulin is given. This dose suppresses the immune response to 2.5 mL of Rh-positive red blood cells. After 12 weeks gestational age, a dose of 300 mcg is recommended. This standard dose of Rho(D) immune globulin (300 mcg) covers FMH up to 15 mL of fetal red cells (30 mL of whole fetal blood). However, there are times when an additional dose is necessary due to massive red blood cell FMH and subsequent maternal immune response. This is when the Kleihauer-Betke (KB) test is essential.</p>
      </sec>
      <sec id="article-23905.s2" sec-type="Specimen Collection">
        <title>Specimen Collection</title>
        <p>The specimen is collected from the maternal patient. This is done through a peripheral venous phlebotomy.</p>
      </sec>
      <sec id="article-23905.s3" sec-type="Procedures">
        <title>Procedures</title>
        <p>In 1864, Korber noted that HbF was resistant to alkali denaturation with NaOH, much more so than adult hemoglobin (HbA). It was further determined that, when immersed in a citrate buffer pH of 3.3, the HbF remained intact&#x000a0;while the HbA leaked out. Utilizing this property, the KB test&#x000a0;was first described in 1957 by&#x000a0;Enno Kleihauer and Klaus Betker.<xref ref-type="bibr" rid="article-23905.r2">[2]</xref>&#x000a0;The KB test is an acid-elution assay performed on maternal blood to determine the amount of HbF that has passed into the maternal circulation. The process exposes maternal blood smears to an acid solution. HbF, resistant to the acid, remains intact, whereas HbA is removed. Following this, the smear is stained via Shepard&#x02019;s method*. The fetal red blood cells are left rose-pink in color, and the maternal cells appear &#x0201c;ghost-like&#x0201d; due to the absence of staining. Though manual detection and quantification had been widely used, flow cytometry was more precise*&#x000a0;and now may be utilized. A total of 2000 cells is counted. Calculating the fetal to maternal cells percentage is used to estimate the total amount of FMH.<xref ref-type="bibr" rid="article-23905.r3">[3]</xref>&#x000a0;The calculation is: percentage of fetal cells = number of fetal cells X 100 / total number of RBCs.</p>
      </sec>
      <sec id="article-23905.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Kleihauer Betke testing has obstetrical implications in the diagnosis and prognosis of preterm labor, fetal demise, and other conditions.&#x000a0;There is some controversy on KB testing in the setting of trauma in pregnancy. This test has been historically only recommended for Rh-negative pregnant patients with major trauma. However, the term "major" is not specifically defined by most authors. Intuitively, however, the risk of FMH would increase with higher magnitude blunt force, anterior placental location, and coagulopathies, among other factors. Some advocate its use in all pregnant trauma patients, including those who are RhD-negative. It has been shown that a positive KB test accurately predicts the risk of preterm labor following trauma, whereas clinical assessment does not.<xref ref-type="bibr" rid="article-23905.r4">[4]</xref>&#x000a0;Because this is an independent risk factor, many authors recommended routine use in the setting of trauma, regardless of Rh status and the mechanism or force of the trauma. The result then is used to guide management and education on prognosis.<xref ref-type="bibr" rid="article-23905.r5">[5]</xref><xref ref-type="bibr" rid="article-23905.r6">[6]</xref><xref ref-type="bibr" rid="article-23905.r7">[7]</xref><xref ref-type="bibr" rid="article-23905.r6">[6]</xref><xref ref-type="bibr" rid="article-23905.r5">[5]</xref></p>
        <p>A study found that the KB&#x000a0;test was not useful to screen for fetal anemia, but instead, it could be used to explain fetal anemia.<xref ref-type="bibr" rid="article-23905.r8">[8]</xref>&#x000a0;Research has also shown the decreased usefulness of systemic KB test after an external cephalic version for breech presentation and in the case of reduced fetal movement during pregnancy.<xref ref-type="bibr" rid="article-23905.r9">[9]</xref><xref ref-type="bibr" rid="article-23905.r10">[10]</xref><xref ref-type="bibr" rid="article-23905.r9">[9]</xref></p>
      </sec>
      <sec id="article-23905.s5" sec-type="Potential Diagnosis">
        <title>Potential Diagnosis</title>
        <p>The rosette test is a qualitative screening test performed on a maternal blood sample to determine if FMH has occurred between an Rh-positive fetus and an Rh-negative mother and serves as a useful screening test. Qualitative testing may be utilized before quantitative testing, ie, if the rosette test is positive, a KB test should be performed to confirm and then subsequently quantify the amount of FMH. In massive trauma, the KB test may be utilized primarily without the preliminary use of the screening rosette test. The&#x000a0;Kleihauer Betke test is utilized to determine if there is fetal blood in maternal circulation, with a threshold of 5 mL.</p>
        <p>The rosette test is performed by incubating the Rh-negative maternal venous whole blood sample with anti-Rho(D) immune globulin. The maternal cells are left unbound to the&#x000a0;anti-Rho(D) as they are Rho(D) negative. During this incubation period, any Rh-positive fetal cells in the maternal sample are sensitized to the anti-Rho(D) immune globulin and bound. Enzyme treated indicator cells are added, only binding to the fetal cells that were present and sensitized, resulting in a process called erythrocyte rosetting or E-rosetting. The indicator cells&#x000a0;are at the center of the rosette, while the fetal RBCs are clustered around the edges, like petals on a flower. This rosetting pattern may then be viewed under microscopy. Kleihauer Betke test is utilized to determine if there is fetal blood in maternal circulation, with a threshold of 5 mL.</p>
      </sec>
      <sec id="article-23905.s6" sec-type="Normal and Critical Findings">
        <title>Normal and Critical Findings</title>
        <p>Any value not reported as zero is abnormal. This value also indicates FMH.</p>
      </sec>
      <sec id="article-23905.s7" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>In the case of maternal persistence of fetal hemoglobin or other maternal hemoglobinopathies that result in elevated HbF, the KB test is falsely positive. Also, flow cytometry must be used to quantify the amount of fetal hemorrhage in maternal circulation.</p>
      </sec>
      <sec id="article-23905.s8" sec-type="Complications">
        <title>Complications</title>
        <p>The KB test is highly specific, with low sensitivity, having a&#x000a0;threshold of 5 mL&#x000a0;of FMH to be positive. Remember that the amount of FMH to cause isoimmunization is only 0.01 mL to 0.03 mL. As such, it is&#x000a0;not&#x000a0;a test to determine if there is FMH but rather to better estimate the amount of FMH. If positive, it is used to determine additional Rho(D) immune globulin dosing over the standard 150 or 300 mcg dosage that should be administered.</p>
      </sec>
      <sec id="article-23905.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Calculating the RhIg Dosage</bold>
</p>
        <p>The following calculations should be used to determine an additional number of vials of Rho(D) immune globulin needed if the KB test is positive, indicating a large amount of FMH.&#x000a0;One vial contains 300 mcg and protects against 30 mL of fetal blood.</p>
        <list list-type="bullet">
          <list-item>
            <p>Volume (mL) of fetal blood = Percentage of fetal cells x 50</p>
          </list-item>
          <list-item>
            <p>Number of Vials of 300 mcg RhIG required = Volume of fetal blood/30 mL</p>
          </list-item>
          <list-item>
            <p>Combining equations:&#x000a0;Number&#x000a0;of vials* = Percentage of fetal cells x 50 / 30
<list list-type="bullet"><list-item><p>* If the number to the right of the decimal point is less than 5,&#x000a0;<bold>round down</bold>&#x000a0;and add&#x000a0;1 vial.</p></list-item><list-item><p>* If the number to the right of the decimal point is greater than or equal to 5,&#x000a0;<bold>round up</bold>&#x000a0;and add&#x000a0;1 vial.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Example 1:&#x000a0; If 2.9% of fetal cells are reported on KB, what dose of RhIG would be required?</p>
        <list list-type="bullet">
          <list-item>
            <p>Volume of fetal blood:&#x000a0; 2.9 x 50 = 145 mL</p>
          </list-item>
          <list-item>
            <p>Number of vials = 145 mL/30 = 4.83</p>
          </list-item>
          <list-item>
            <p>The decimal is greater than 5; therefore, round up and add 1 vial (5+1).</p>
          </list-item>
          <list-item>
            <p>Answer: 6 vials</p>
          </list-item>
        </list>
        <p>Example 2:&#x000a0; If 2.6% of fetal cells are reported on KB, what dose of RhIG would be required?</p>
        <list list-type="bullet">
          <list-item>
            <p>Volume of fetal blood: 2.6% x 50 = 130 mL</p>
          </list-item>
          <list-item>
            <p>Number of vials = 130 mL/30 = 4.33</p>
          </list-item>
          <list-item>
            <p>The decimal is less than 5; therefore, round down and add 1 vial (4+1).</p>
          </list-item>
          <list-item>
            <p>Answer: 5 vials</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23905.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23905&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23905">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23905/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23905">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23905.s11">
        <title>References</title>
        <ref id="article-23905.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Saltzman</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Herndon</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Homicide: a leading cause of injury deaths among pregnant and postpartum women in the United States, 1991-1999.</article-title>
            <source>Am J Public Health</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>95</volume>
            <issue>3</issue>
            <fpage>471</fpage>
            <page-range>471-7</page-range>
            <pub-id pub-id-type="pmid">15727979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23905.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>KLEIHAUER</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>BRAUN</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>BETKE</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Demonstration of fetal hemoglobin in erythrocytes of a blood smear].</article-title>
            <source>Klin Wochenschr</source>
            <year>1957</year>
            <month>Jun</month>
            <day>15</day>
            <volume>35</volume>
            <issue>12</issue>
            <fpage>637</fpage>
            <page-range>637-8</page-range>
            <pub-id pub-id-type="pmid">13450287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23905.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pelikan</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Mesker</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Scherjon</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Kanhai</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Tanke</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Improvement of the Kleihauer-Betke test by automated detection of fetal erythrocytes in maternal blood.</article-title>
            <source>Cytometry B Clin Cytom</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">12827662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23905.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kush</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Muench</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Harman</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Baschat</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Persistent fetal hemoglobin in maternal circulation complicating the diagnosis of fetomaternal hemorrhage.</article-title>
            <source>Obstet Gynecol</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>105</volume>
            <issue>4</issue>
            <fpage>872</fpage>
            <page-range>872-4</page-range>
            <pub-id pub-id-type="pmid">15802419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23905.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muench</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Baschat</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>UM</given-names>
              </name>
              <name>
                <surname>Mighty</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Scalea</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Harman</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Kleihauer-betke testing is important in all cases of maternal trauma.</article-title>
            <source>J Trauma</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>1094</fpage>
            <page-range>1094-8</page-range>
            <pub-id pub-id-type="pmid">15580038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23905.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Girard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marchand</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Uch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bretelle</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>[Trauma and pregnancy: Is the Kleihauer-Betke test really useful?].</article-title>
            <source>Gynecol Obstet Fertil Senol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>45</volume>
            <issue>11</issue>
            <fpage>584</fpage>
            <page-range>584-589</page-range>
            <pub-id pub-id-type="pmid">28967599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23905.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murphy</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Quinlan</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Trauma in pregnancy: assessment, management, and prevention.</article-title>
            <source>Am Fam Physician</source>
            <year>2014</year>
            <month>Nov</month>
            <day>15</day>
            <volume>90</volume>
            <issue>10</issue>
            <fpage>717</fpage>
            <page-range>717-22</page-range>
            <pub-id pub-id-type="pmid">25403036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23905.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bataille</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Petit</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Winer</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Performance of the Kleihauer Betke test in the prediction of neonatal anemia.</article-title>
            <source>J Matern Fetal Neonatal Med</source>
            <year>2022</year>
            <month>Oct</month>
            <volume>35</volume>
            <issue>19</issue>
            <fpage>3670</fpage>
            <page-range>3670-3676</page-range>
            <pub-id pub-id-type="pmid">33106065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23905.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lemaitre</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Planche</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ducarme</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Systematic Kleihauer-Betke Test after External Cephalic Version for Breech Presentation: Is It Useful?</article-title>
            <source>J Clin Med</source>
            <year>2020</year>
            <month>Jun</month>
            <day>30</day>
            <volume>9</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">32629792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23905.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Athiel</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Maisonneuve</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bl&#x000e9;as</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maurice</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cortey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Toly-Ndour</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huguet-Jacquot</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mailloux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jouannic</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Reduced fetal movement during pregnancy: Is the Kleihauer-Betke test really useful?</article-title>
            <source>J Gynecol Obstet Hum Reprod</source>
            <year>2020</year>
            <month>May</month>
            <day>11</day>
            <fpage>101748</fpage>
            <pub-id pub-id-type="pmid">32438135</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
